As of 2024-12-15, the Relative Valuation of IDEAYA Biosciences Inc (IDYA) is (23.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.19 USD, the upside of IDEAYA Biosciences Inc based on Relative Valuation is -193.5%.
The range of the Relative Valuation is (10.51) - (35.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 17.3x | 11.0x |
| Forward P/E multiples | 5.1x - 18.5x | 11.8x |
| Fair Price | (10.51) - (35.65) | (23.55) |
| Upside | -141.7% - -241.5% | -193.5% |
| Date | P/E |
| 2024-12-11 | -13.19 |
| 2024-12-10 | -13.47 |
| 2024-12-09 | -13.46 |
| 2024-12-06 | -13.48 |
| 2024-12-05 | -12.80 |
| 2024-12-04 | -13.76 |
| 2024-12-03 | -12.94 |
| 2024-12-02 | -13.32 |
| 2024-11-29 | -13.28 |
| 2024-11-27 | -13.10 |
| 2024-11-26 | -12.99 |
| 2024-11-25 | -12.88 |
| 2024-11-22 | -13.00 |
| 2024-11-21 | -12.91 |
| 2024-11-20 | -12.39 |
| 2024-11-19 | -12.55 |
| 2024-11-18 | -12.71 |
| 2024-11-15 | -12.93 |
| 2024-11-14 | -14.30 |
| 2024-11-13 | -14.79 |
| 2024-11-12 | -15.03 |
| 2024-11-11 | -15.52 |
| 2024-11-08 | -15.18 |
| 2024-11-07 | -14.55 |
| 2024-11-06 | -14.76 |
| 2024-11-05 | -14.35 |
| 2024-11-04 | -14.56 |
| 2024-11-01 | -13.88 |
| 2024-10-31 | -13.66 |
| 2024-10-30 | -14.30 |
| 2024-10-29 | -14.49 |
| 2024-10-28 | -14.56 |
| 2024-10-25 | -14.22 |
| 2024-10-24 | -14.17 |
| 2024-10-23 | -14.31 |
| 2024-10-22 | -14.66 |
| 2024-10-21 | -14.98 |
| 2024-10-18 | -14.82 |
| 2024-10-17 | -14.89 |
| 2024-10-16 | -15.04 |
| 2024-10-15 | -14.95 |
| 2024-10-14 | -14.79 |
| 2024-10-11 | -14.99 |
| 2024-10-10 | -14.65 |
| 2024-10-09 | -14.30 |
| 2024-10-08 | -15.07 |
| 2024-10-07 | -14.27 |
| 2024-10-04 | -14.54 |
| 2024-10-03 | -14.19 |
| 2024-10-02 | -15.38 |